Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 2
ClinicalTrials.gov
Phase 2 Study of Microdoses of Ranibizumab in Diabetic Macular Edema - the MINIMA 2 Study
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01112085
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
INTERVENTIONAL
Inicio: 14 de abr de 2022
ID: NCT05208047
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12-week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of SAR440340 and the Coadministration of SAR440340 and Dupilumab in Patients With Moderate-to-Severe Asthma Who Are Not Well Controlled on Inhaled Corticosteroid (ICS) Plus Long-acting β2 Adrenergic Agonist (LABA) Therapy
INTERVENTIONAL
Inicio: 12 de mar de 2018
ID: NCT03387852
Completado
Fase 2
ClinicalTrials.gov
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00594984
Aún no recluta
Fase 4
ClinicalTrials.gov
Efficacy and Safety of Doravirine in the Rapid Initiation of Highly Active Antiretroviral Therapy (HAART) in HIV-1positive Patients Without Prior Treatment
INTERVENTIONAL
Inicio: 13 de jul de 2026
ID: NCT07357584
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Systemic Sclerosis
INTERVENTIONAL
Inicio: 4 de jul de 2022
ID: NCT05016804
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC).
INTERVENTIONAL
Inicio: 3 de nov de 2015
ID: NCT02542293
Completado
ClinicalTrials.gov
Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using "Easypod™" Electromechanical Device for Growth Hormone Treatment in Argentina
OBSERVATIONAL
Inicio: 31 de mar de 2013
ID: NCT01582334
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00968708
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)
INTERVENTIONAL
Inicio: 22 de dic de 2020
ID: NCT04677543
Desconocido
ClinicalTrials.gov
Reduced Frequency Hemodialysis in Prevalent Patients Due to the Coronavirus Disease
OBSERVATIONAL
Inicio: 20 de mar de 2020
ID: NCT04374058
Completado
Fase 3
ClinicalTrials.gov
A Randomized Placebo Controlled Study of OSI-774 (Erlotinib HCl, Tarceva[TM]) in Patients With Incurable Stage IIIB/IV Non-small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00036647
Completado
Fase 3
ClinicalTrials.gov
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 2 de ago de 2016
ID: NCT02757352
Completado
ClinicalTrials.gov
A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
OBSERVATIONAL
Inicio: 20 de jul de 2020
ID: NCT04431414
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)
INTERVENTIONAL
Inicio: 22 de mar de 2023
ID: NCT05767034
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib
INTERVENTIONAL
Inicio: 14 de may de 2013
ID: NCT01774344
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01234311
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00406640
Completado
Fase 4
ClinicalTrials.gov
A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de jul de 2015
ID: NCT02465515
Completado
ClinicalTrials.gov
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
OBSERVATIONAL
Inicio: 22 de abr de 2019
ID: NCT03871816
Anterior
1
...
425
426
427
...
434
Siguiente
Filtros